4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-043464
Chief Medical Officer bought 2,000 shares at $5.26 ($10,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lindmark Bertil Chief Medical Officer | 2021-06-28 | Purchase | +2,000 | $5.26 | $10,520 | 2,000 | D |
| Open-market purchases · 2,000 sh · avg $5.26 · $10,520 | |||||||
Loading xslF345X03/doc4.xml…